🟡 60/100

Review before taking

  • Melatonin: 20mg is 2.0× the Tolerable Upper Intake Level (10mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Melatonin: 20mg is 2.0× the Tolerable Upper Intake Level (10mg)

The safety score is low because the 20mg dose of melatonin is twice the recommended maximum daily limit of 10mg.

Label Data

1 Capsule(s) Serving Size
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

20 mg
⚠️ Exceeds Tolerable Upper Intake Level by 2.0× (UL: 10 mg) 📚 236 studies (Tier A: 2, B: 109)
This product: 20mg UL 10mg

Other Ingredients

Microcrystalline Cellulose Gelatin Capsule

Label Claims — Verification

All Other
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years) Halal Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use: One capsule per day or as directed by a healthcare professional.

⚠️ Warnings & Precautions

Keep out of the reach of children.

Safety sealed for your protection.

🧪 Formulation Notes

Contains No: Dairy, egg, fish, shellfish, nuts, wheat, gluten, soy, sugar, yeast, artificial preservatives or colors.

Halal certified.

Gluten free Non GMO

cGMP Current Good Manufacturing Practice

Additional Information

Store tightly closed in a cool, dry place.

Energy = Health

cGMP Current Good Manufacturing Practice

PNR Over 100 Partners in Research

ISWA Halal

Made in the USA

Product Details

UPC / SKU 7 05105 10760 6
DSLD Entry Date 2020-04-23
Product Type Non-Nutrient/Non-Botanical
Form Capsule
DSLD ID 217283
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →